Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06182280 · ClinicalTrials.gov registry record · NA

Transmaculine One-on-One and Group Empowerment for Targeted HIV Reduction

A NA study, sponsored by Fenway Community Health.

Not yet
Registry status
NA
Development phase
375
Enrollment target

NCT06182280 is a NA study that has not yet begun recruiting, run by Fenway Community Health. The registered enrollment target is 375 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06182280, a NA study, has not yet begun recruiting, sponsored by Fenway Community Health.

NOT YET RECRUITING
Registry status
NA
Development phase
375 participants
Enrollment target

Study Summary

Transgender masculine and gender diverse people who have sex with men (TMSM) have an increased risk of HIV and face unique barriers engaging in prevention services. Digitally delivered support interventions addressing HIV prevention barriers delivered by peers in one-on-one or small-group settings may be effective at increasing PrEP engagement. This study examines the independent and combined effects of individual and group-based peer-support interventions on PrEP outcomes. Participants will be randomly assigned to receive: (i) standard-of-care HIV prevention information, (ii) a one-on-one healthy lifestyle intervention tailored for transgender masculine people, (iii) a peer-group based healthy lifestyle intervention for transgender masculine people, or (iv) both the one-on-one and group-based interventions delivered together. The hypotheses are that the individual group-based interventions will result in higher PrEP uptake and persistence than the standard of care and that the combined interventions will be more effective than receiving one individual intervention.

Interventions

  • BEHAVIORAL PrEP4T
  • BEHAVIORAL LS4TM

Trial Details

FieldValue
Enrollment Target 375 participants
Start Date 2024-01
Est. Completion 2027-06
Phase NA

Sponsor

Fenway Community Health

14 total trials

What the Registry Record Tells You About NCT06182280

The ClinicalTrials.gov registry entry for NCT06182280 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fenway Community Health, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which PrEP4T is the first listed.

NCT06182280 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06182280 about?

NCT06182280 is a clinical study titled "Transmaculine One-on-One and Group Empowerment for Targeted HIV Reduction". Transgender masculine and gender diverse people who have sex with men (TMSM) have an increased risk of HIV and face unique barriers engaging in prevention services. Digitally delivered support interventions addressing HIV prevention barriers delivered by peers in one-on-one or small-group settings m...

What is the current status of trial NCT06182280?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 375 participants. The study started on 2024-01. Estimated completion is 2027-06.

What interventions are being tested in trial NCT06182280?

The interventions under investigation include: PrEP4T (BEHAVIORAL), LS4TM (BEHAVIORAL).

Who is sponsoring clinical trial NCT06182280?

This trial is sponsored by Fenway Community Health, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.